Literature DB >> 4564205

In vivo production of an RNA-DNA copolymer after infection of Escherichia coli by bacteriophage T4.

P J Buckley, L D Kosturko, A W Kozinski.   

Abstract

An RNA-DNA copolymer was isolated from Escherichia coli infected with bacteriophage T4. The RNA and DNA are covalently linked, and in the same polynucleotide strand. The DNA of the copolymer hybridizes specifically to the left strand of phage T4 DNA. The copolymer is produced in cells infected with amber mutants of phage T4 deficient in DNA replication and is not inhibited by the addition of chloramphenicol.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4564205      PMCID: PMC389727          DOI: 10.1073/pnas.69.11.3165

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  7 in total

1.  Fractionation of the complementary strands of coliphage T4 DNA based on the asymmetric distribution of the poly U and poly U,G binding sites.

Authors:  A Guha; W Szybalski
Journal:  Virology       Date:  1968-04       Impact factor: 3.616

2.  Unbiased participation of T4 phage DNA strands in replication.

Authors:  A W Kozinski
Journal:  Biochem Biophys Res Commun       Date:  1969-04-29       Impact factor: 3.575

3.  Early intracellular events in the replication of T4 phage DNA. I. Complex formation of replicative DNA.

Authors:  A W Kozinski; T H Lin
Journal:  Proc Natl Acad Sci U S A       Date:  1965-07       Impact factor: 11.205

4.  Controls and polarity of transcription during bacteriophage T4 development.

Authors:  A Guha; W Szybalski; W Salser; E P Geiduschek; J F Pulitzer; A Bolle
Journal:  J Mol Biol       Date:  1971-07-28       Impact factor: 5.469

5.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

6.  A possible role for RNA polymerase in the initiation of M13 DNA synthesis.

Authors:  D Brutlag; R Schekman; A Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

7.  Molecular recombination in T4 bacteriophage deoxyribonucleic acid. I. Tertiary structure of early replicative and recombining deoxyribonucleic acid.

Authors:  A W Kozinski; P B Kozinski; R James
Journal:  J Virol       Date:  1967-08       Impact factor: 5.103

  7 in total
  8 in total

1.  Biological activity of T4 DNA synthesized in toluene-treated Escherichia coli cells.

Authors:  L A McNicol; R C Miller
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

2.  Continued synthesis of bacterial DNA after infection by bacteriophage T4.

Authors:  M S Scofield; W L Collinsworth; C K Mathews
Journal:  J Virol       Date:  1974-04       Impact factor: 5.103

3.  Effect of inhibition of macromolecule synthesis on the association of bacteriophage T4 DNA with membrane.

Authors:  C F Earhart; C J Sauri; G Fletcher; J L Wulff
Journal:  J Virol       Date:  1973-04       Impact factor: 5.103

4.  Replication of T4 DNA in Escherichia coli treated with toluene.

Authors:  R C Miller; D M Taylor; K MacKay; H W Smith
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

5.  Transforming ability of a T4 RNA-DNA copolymer.

Authors:  L A McNicol
Journal:  J Virol       Date:  1973-08       Impact factor: 5.103

6.  Size and base composition of RNA in supercoiled plasmid DNA.

Authors:  H Williams; H W Boyer; D R Helsinki
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

7.  Two alternative mechanisms for initiation of DNA replication forks in bacteriophage T4: priming by RNA polymerase and by recombination.

Authors:  A Luder; G Mosig
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

8.  Effect of inhibitors of ribonucleic acid and protein synthesis on the cyclic adenosine monophosphate stimulation of plasmid ColE1 replication.

Authors:  L Katz; D R Helinski
Journal:  J Bacteriol       Date:  1974-08       Impact factor: 3.490

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.